Susan Hasty, Publisher
Table of Contents . . . January 17th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Vaccine Week | Other Publications
HIV/AIDS Therapy - Proinflammatory potential of microbicide candidates assessed
Business Update - Pharma company acquires intellectual property right in immunotherapy
Cancer Vaccine - Phase I study for antitumor CEA-TRICOM published
Drug Development - Company gets $12 million for Macroflux projects, requests U.S. FDA meeting
Epidemiology - Number of sex workers in Vietnamese city estimated to gauge HIV risks
HIV/AIDS Infection - Model of oral HIV exposure reveals extensive tonsil binding of HIV
HIV/AIDS Screening - Company completes trials for two HIV rapid tests; nears PMA submission
HIV/AIDS Therapy - Invirase receives FDA marketing approval
HIV/AIDS Therapy - Vaginal microbicide trials guided using biomarkers of inflammation
Legal Issues - Family sues over death of Memphis woman killed by AIDS treatment
Leishmaniasis - Pharmaceutical company receives approval to market leishmaniasis drug in Germany
Patent - Drug development company issued patent for regulation of mismatch repair
Personnel - Anita Smith to co-chair presidential HIV/AIDS advisory committee
Smallpox Vaccine - Protein and genome analysis company awarded grant to develop smallpox vaccine
Tetanus Vaccine - Tetanus vaccination with IL-2 during HAART induces sustained T-cell responses
Vaccine Development - Biopharma company submits marketing authorization for StaphVAX
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.